SHBG and breast cancer: A trend of increasing breast cancer risk with increasing E2/SHBG ratio was found in the placebo group (trend per quartile 1·25 [1·08–1·45], p = 0·0033), but not in the anastrozole group (HR = 1·06 [0·86–1·30], p = 0·60; Fig. 6).